Redefining Bioprocessing

Our unique platform enables fast, flexible and cost-effective biologics development and manufacturing for biopharmaceutical companies.

We have an extensive track record and a thorough knowledge of continuous bioprocessing. Strong partnerships with industry have given us opportunities to test our system with a variety of demands focusing on speed, cost efficiency and quality improvements.

As simAbs, we distinguish ourselves in the field by offering an integrated approach of a total solution service, a customer focused mentality, and our expert know-how. We ensure an incomparable journey.

Welcome to simAbs – Smart Integrated Manufacturing of Antibodies

Are you looking for more consistent quality biologics?

Do you wish to have high viability in your cell culture?

Do you want to have your product available quicker?

Do you need a more cost-efficient process for your product?

Are you eager to increase your productivity and product titer?

Are you looking for the production of nanobodies or bispecifics?

Dreaming of finding a company who will produce smaller quantities of biologics for your study?

Do you need feasibility studies or proofs of concept for your R&D or preclinical phase?

Are you looking for GMP production of your biologicals?

Benefits of using the simAbs Platform

simAbs Features

Benefits for You

Consistently high product quality compared to batch processes

High viability, less aggregation, fragments, and variability

High productivity and smaller footprint

Lower cost

Quick setup and reduced downtime

Faster to market

Flexible options: bispecific antibodies, Fabs, antibody-drug conjugates (ADC) and nanobodies

We can adapt to your needs

Benefits of using the simAbs Platform

simAbs Features

Consistently high product quality compared to batch processes

High productivity and smaller footprint

Quick setup and reduced downtime

Flexible options: bispecific antibodies, Fabs, antibody-drug conjugates (ADC) and nanobodies

Benefits for You

High viability, less aggregation, fragments, and variability

Lower cost

Faster to market

We can adapt to your needs

Process Development

We have developed flexible continuous manufacturing processes which allow you to increase speed to market, providing a consistently high-quality and cost-effective product.

Cell Line Development

simAbs has a proprietary cell line technology for stable recombinant protein production based on CHO cells in a continuous perfusion system.

Additional Services

simAbs provides complete GMP services including development and manufacturing, project management, quality and regulatory assistance.

It is a great pleasure to join forces with simAbs. The combination of academic creativity for cell line development with simAbs’ most recent perfusion technologies provides unique opportunities."

Prof. Dr. Kim De KeersmaeckerDepartment of Oncology, KU Leuven

simAbs is a knowledge-based company with experienced and capable staff in the expression, production and purification of biomolecules. It is invaluable that simAbs keeps its promises in the best possible way.

“simAbs strengthens the portfolio of companies in Flanders that develop innovative biopharmaceutical continuous production technologies. Innovation in such manufacturing technologies is essential to enable the production of pharmaceutical therapeutics of the future. simAbs immediately implements process analytical systems in its technology that evaluate and guarantee product quality during the production process.”

Prof. Dr. Thomas De BeerFaculty of Pharmaceutical Sciences, UGent

Read our latest news

Welcome to our new website!

April 13, 2022

We are looking for an Automation Engineer

March 25, 2022